Selective Cyclooxygenase‐2 Inhibition Prevents Alveolar Bone Loss in Experimental Periodontitis in Rats

Abstract

COX inhibition prevented ABL in this experimental periodontal disease model. MLX displays similar efficacy and less gastric damage than IND. MLX may provide a better risk/benefit ratio in the treatment of human periodontitis than non-selective COX inhibitors.